News stories about Itron (NASDAQ:ITRI) have been trending positive on Saturday, Accern reports. Accern scores the sentiment of media coverage by reviewing more than 20 million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Itron earned a coverage optimism score of 0.33 on Accern’s scale. Accern also gave news articles about the scientific and technical instruments company an impact score of 45.8687792400045 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the near future.

Here are some of the news headlines that may have effected Accern Sentiment’s rankings:

Shares of Itron (ITRI) opened at $69.20 on Friday. The stock has a market capitalization of $2,700.00, a price-to-earnings ratio of 24.69, a PEG ratio of 1.07 and a beta of 1.00. The company has a quick ratio of 1.26, a current ratio of 1.67 and a debt-to-equity ratio of 0.38. Itron has a 52 week low of $57.80 and a 52 week high of $79.95.

Itron (NASDAQ:ITRI) last announced its quarterly earnings data on Wednesday, November 1st. The scientific and technical instruments company reported $0.77 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.89 by ($0.12). The company had revenue of $486.75 million during the quarter, compared to analyst estimates of $526.55 million. Itron had a net margin of 3.42% and a return on equity of 14.84%. The firm’s revenue was down 4.0% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.77 earnings per share. analysts anticipate that Itron will post 2.99 EPS for the current year.

A number of research analysts have commented on the company. Canaccord Genuity restated a “hold” rating and set a $78.00 price target on shares of Itron in a research note on Friday, October 6th. JMP Securities set a $102.00 price target on Itron and gave the stock a “buy” rating in a research note on Thursday, October 12th. Zacks Investment Research cut Itron from a “buy” rating to a “hold” rating in a research note on Tuesday, September 19th. Finally, Argus restated a “buy” rating and set a $80.00 price target (up from $78.00) on shares of Itron in a research note on Tuesday, September 12th. One research analyst has rated the stock with a sell rating, four have issued a hold rating and five have given a buy rating to the stock. The company presently has a consensus rating of “Hold” and a consensus target price of $81.78.

In other Itron news, major shareholder Scopia Capital Management Lp bought 541,753 shares of the company’s stock in a transaction that occurred on Friday, December 8th. The shares were purchased at an average price of $69.44 per share, with a total value of $37,619,328.32. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Corporate insiders own 2.03% of the company’s stock.

COPYRIGHT VIOLATION NOTICE: This report was posted by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are viewing this report on another site, it was illegally stolen and republished in violation of U.S. & international copyright laws. The original version of this report can be read at https://www.thecerbatgem.com/2017/12/09/itron-itri-receives-daily-news-sentiment-rating-of-0-33.html.

About Itron

Itron, Inc (Itron) is a technology and service company. The Company provides solutions that measure, manage and analyze energy and water use. The Company operates through three segments: Electricity, Gas and Water. It provides a portfolio of products, solutions, software and services to electric, gas and water utility customers across the globe.

Insider Buying and Selling by Quarter for Itron (NASDAQ:ITRI)

Receive News & Stock Ratings for Itron Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Itron Inc. and related stocks with our FREE daily email newsletter.